These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15465274)

  • 21. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology.
    Newman J; Rissman RA; Sarsoza F; Kim RC; Dick M; Bennett DA; Cotman CW; Rohn TT; Head E
    Acta Neuropathol; 2005 Aug; 110(2):135-44. PubMed ID: 15986225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human tau pathology transmits glial tau aggregates in the absence of neuronal tau.
    Narasimhan S; Changolkar L; Riddle DM; Kats A; Stieber A; Weitzman SA; Zhang B; Li Z; Roberson ED; Trojanowski JQ; Lee VMY
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31826239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases.
    Schwab C; DeMaggio AJ; Ghoshal N; Binder LI; Kuret J; McGeer PL
    Neurobiol Aging; 2000; 21(4):503-10. PubMed ID: 10924763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytes.
    Goldbaum O; Richter-Landsberg C
    Glia; 2002 Dec; 40(3):271-82. PubMed ID: 12420308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
    Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
    Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
    Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.
    Dickson DW; Feany MB; Yen SH; Mattiace LA; Davies P
    J Neural Transm Suppl; 1996; 47():31-46. PubMed ID: 8841955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.
    Uryu K; Richter-Landsberg C; Welch W; Sun E; Goldbaum O; Norris EH; Pham CT; Yazawa I; Hilburger K; Micsenyi M; Giasson BI; Bonini NM; Lee VM; Trojanowski JQ
    Am J Pathol; 2006 Mar; 168(3):947-61. PubMed ID: 16507910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome.
    Gunawardana CG; Mehrabian M; Wang X; Mueller I; Lubambo IB; Jonkman JE; Wang H; Schmitt-Ulms G
    Mol Cell Proteomics; 2015 Nov; 14(11):3000-14. PubMed ID: 26269332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquilin 2 is not associated with tau pathology.
    Nölle A; van Haastert ES; Zwart R; Hoozemans JJ; Scheper W
    PLoS One; 2013; 8(9):e76598. PubMed ID: 24086754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
    Götz J; Tolnay M; Barmettler R; Chen F; Probst A; Nitsch RM
    Eur J Neurosci; 2001 Jun; 13(11):2131-40. PubMed ID: 11422454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX.
    Uchihara T; Endo K; Kondo H; Okabayashi S; Shimozawa N; Yasutomi Y; Adachi E; Kimura N
    Acta Neuropathol Commun; 2016 Nov; 4(1):118. PubMed ID: 27842611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in clinical neurosciences: Frontotemporal dementia-pick's disease.
    Kertesz A
    Can J Neurol Sci; 2006 May; 33(2):141-8. PubMed ID: 16736722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of proteasome inhibition by MG-132 on HSP27 oligomerization, phosphorylation, and aggresome formation in the OLN-93 oligodendroglia cell line.
    Bolhuis S; Richter-Landsberg C
    J Neurochem; 2010 Aug; 114(4):960-71. PubMed ID: 20089131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of autophagy by rapamycin does not protect oligodendrocytes against protein aggregate formation and cell death induced by proteasomal inhibition.
    Noack M; Richter-Landsberg C
    J Mol Neurosci; 2015 Jan; 55(1):99-108. PubMed ID: 25069858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration").
    Reed LA; Schmidt ML; Wszolek ZK; Balin BJ; Soontornniyomkij V; Lee VM; Trojanowski JQ; Schelper RL
    J Neuropathol Exp Neurol; 1998 Jun; 57(6):588-601. PubMed ID: 9630238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.